Low-dose cytarabine for acute myeloid leukaemia and myelodysplastic syndromes: in vivo and in vitro cytotoxicity
- 31 July 1991
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (7), 842-845
- https://doi.org/10.1016/0277-5379(91)90130-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Low dose cytosine-arabinoside has only minimal differentiation inducing capacity in HL60 cellsEuropean Journal of Cancer and Clinical Oncology, 1989
- 1-B-D arabinofuranosyl cytosine and all-trans retinoic acid in combination accelerates and increases monocyte differentiation of myeloid leukemic cellsLeukemia Research, 1986
- Granulocyte functions during maturation of human promyelocytic leukemia cellsLeukemia Research, 1985
- Induction of differentiation of human acute non-lymphocytic leukemia cells in primary culture by inducers of differentiation of human myeloid leukemia cell line HL-60European Journal of Cancer and Clinical Oncology, 1983
- Treatment of acute myelocytic leukemia with low-dose cytosine arabinoside: Results of a pilot study in four patientsLeukemia Research, 1983
- Clonal analysis of the response of HL60 human myeloid leukemia cells to biological regulatorsLeukemia Research, 1983
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- Small doses of ARA-C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells?British Journal of Haematology, 1982